| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Athersys Inc (NASDAQ: ATHX)
ATHX Technical Analysis
5
| As on 11th Mar 2024 ATHX SHARE Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.10 & Strong Sell for SHORT-TERM with Stoploss of 1.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATHXSHARE Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | -0.01 | -50.00 |
| Volume | 135467 | 1 Year | -1.62 | -99.39 |
| 52 Week High 2.69 | 52 Week Low 0.01 | ||||
NASDAQ USA Most Active Stocks
| AGMH | 0.06 | 100.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 102.71 | 3.86% |
| TSLA | 250.74 | 5.37% |
| OPEN | 0.84 | -15.15% |
| LCID | 2.39 | 2.58% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| AAL | 9.32 | 0.11% |
| INTC | 20.59 | 5.54% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATHX Daily Charts |
ATHX Intraday Charts |
Whats New @ Bazaartrend |
ATHX Free Analysis |
|
|
ATHX Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
ATHX Forecast April 2025
| 4th UP Forecast | 4.37 |
| 3rd UP Forecast | 2.97 |
| 2nd UP Forecast | 2.11 |
| 1st UP Forecast | 1.24 |
| 1st DOWN Forecast | -1.22 |
| 2nd DOWN Forecast | -2.09 |
| 3rd DOWN Forecast | -2.95 |
| 4th DOWN Forecast | -4.35 |
ATHX Weekly Forecast
| 4th UP Forecast | 1.46 |
| 3rd UP Forecast | 0.99 |
| 2nd UP Forecast | 0.71 |
| 1st UP Forecast | 0.42 |
| 1st DOWN Forecast | -0.40 |
| 2nd DOWN Forecast | -0.69 |
| 3rd DOWN Forecast | -0.97 |
| 4th DOWN Forecast | -1.44 |
ATHX Forecast2025
| 4th UP Forecast | 5.33 |
| 3rd UP Forecast | 3.62 |
| 2nd UP Forecast | 2.57 |
| 1st UP Forecast | 1.51 |
| 1st DOWN Forecast | -1.49 |
| 2nd DOWN Forecast | -2.55 |
| 3rd DOWN Forecast | -3.6 |
| 4th DOWN Forecast | -5.31 |
Athersys Inc ( NASDAQ USA Symbol : ATHX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATHX Business Profile
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as in Phase II clinical study for the treatment of patients with acute myocardial infarction, and has completed Phase I clinical study for the treatment of patients suffering from leukemia or various other blood-borne cancers. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio. Address: 3201 Carnegie Avenue, Cleveland, OH, United States, 44115-2634
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service